Exact Mass: 393.1079

amsacrine

C21H19N3O3S (393.1147)

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007364 - Intercalating Agents L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents D000970 - Antineoplastic Agents

Amsacrine

C21H19N3O3S (393.1147)

Aminoacridine derivative that is a potent intercalating antineoplastic agent. It is effective in the treatment of acute leukemias and malignant lymphomas, but has poor activity in the treatment of solid tumors. It is frequently used in combination with other antineoplastic agents in chemotherapy protocols. It produces consistent but acceptable myelosuppression and cardiotoxic effects. [PubChem] C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007364 - Intercalating Agents L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents D000970 - Antineoplastic Agents

RD 01A3

C18H19NO9 (393.106)

Cephathrindole A

C24H15N3O3 (393.1113)

Cephathrindole B

C24H15N3O3 (393.1113)

SCHEMBL16724509

C23H15N5S (393.1048)

MMV228911

C21H19N3O3S (393.1147)

CHEMBL4586052

C22H19NO4S (393.1035)

h_255_rad140

C20H16ClN5O2 (393.0992)

bis[4-(1,1-dimethylethyl)phenyl]-Iodonium

C20H26I+ (393.1079)

Fmoc-β-(2-thienyl)-D-alanine

C22H19NO4S (393.1035)

FMOC-3-L-ALA(2-THIENYL)-OH

C22H19NO4S (393.1035)

Fmoc-(R)-3-Amino-3-(2-thienyl)-propionic acid

C22H19NO4S (393.1035)

7-[(3R)-3-isothiocyanatopyrrolidin-1-yl]-N,N-dimethyl-2,1,3-benzoxadiazole-4-sulfonamide

C16H19N5O5S (393.1107)

Fmoc-D-3-Thienylalanine

C22H19NO4S (393.1035)

4,4,4-(1,3,5-Triazine-2,4,6-triyl)tris[benzaldehyde]

C24H15N3O3 (393.1113)

FMoc-L-3-Thienylalanine

C22H19NO4S (393.1035)

Testolone

C20H16ClN5O2 (393.0992)

C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent

2-(4-Ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]pyrazolo[1,5-b]pyridazine

C21H19N3O3S (393.1147)

2-(Biphenyl-4-sulfonyl)-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid

C22H19NO4S (393.1035)

SB-218078

C24H15N3O3 (393.1113)

4-{2-[(4-fluorophenyl)sulfonyl]acetyl}-2,6-dimethylphenyl N,N-dimethylcarbamate

C19H20FNO5S (393.1046)

N-[2-(2,4-dimethylphenyl)-4,6-dihydrothieno[3,4-c]pyrazol-3-yl]-1,3-benzodioxole-5-carboxamide

C21H19N3O3S (393.1147)

2-(4-chlorophenyl)-8-methylimidazo[1,2-a]pyridine-3-carbaldehyde O-(3-fluorobenzyl)oxime

C22H17ClFN3O (393.1044)

2-(4-chlorophenyl)-7-methylimidazo[1,2-a]pyridine-3-carbaldehyde O-(3-fluorobenzyl)oxime

C22H17ClFN3O (393.1044)

Rel-(9R,12S)-9,10,11,12-tetrahydro-9,12-epoxy-1H-diindolo[1,2,3-FG:3,2,1-KL]pyrrolo[3,4-I][1,6]benzodiazocine-1,3(2H)-dione

C24H15N3O3 (393.1113)

N-{3-[(3-methoxyphenyl)carbamoyl]-5,6-dihydro-4H-cyclopenta[b]thiophen-2-yl}pyridine-3-carboxamide

C21H19N3O3S (393.1147)

n-[2-(4-Phenoxybenzyl)benzimidazol-5-yl]methanesulphonamide

C21H19N3O3S (393.1147)

4-[(Z)-[1-(4-cyanophenyl)-5-oxo-3-phenylpyrazol-4-ylidene]methyl]benzoic acid

C24H15N3O3 (393.1113)

Isopropyl 6-methyl-2-[(phenylsulfonyl)amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylate

C19H23NO4S2 (393.1068)

3-{[1-(3-Chloro-phenyl)-3-methyl-5-oxo-1,5-dihydro-pyrazol-4-ylidenemethyl]-amino}-2-methyl-3H-quinazolin-4-one

C20H16ClN5O2 (393.0992)

3-fluoro-N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3-oxanyl]benzamide

C18H20FN3O4S (393.1158)

3-fluoro-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3-oxanyl]benzamide

C18H20FN3O4S (393.1158)

3-fluoro-N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3-oxanyl]benzamide

C18H20FN3O4S (393.1158)

3-fluoro-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3-oxanyl]benzamide

C18H20FN3O4S (393.1158)

3-fluoro-N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3-oxanyl]benzamide

C18H20FN3O4S (393.1158)

3-fluoro-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(2-thiazolylamino)ethyl]-3-oxanyl]benzamide

C18H20FN3O4S (393.1158)

2-[(2,5-dimethylphenyl)thio]acetic acid [3-(1H-benzimidazol-2-yl)-3-cyano-2-oxopropyl] ester

C21H19N3O3S (393.1147)

5-[[4-[(Z)-2-cyano-2-(4-fluorophenyl)ethenyl]-2-methoxyphenoxy]methyl]furan-2-carboxylic acid

C22H16FNO5 (393.1012)

2-chloro-4-[[(1R)-1-[5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]-2-hydroxypropyl]amino]-3-methylbenzonitrile

C20H16ClN5O2 (393.0992)

2-[(2s)-2-[(1r)-1-carboxyethyl]-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-6-yl]pentanedioic acid

C18H19NO9 (393.106)

2-[2-(1-carboxyethyl)-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-6-yl]pentanedioic acid

C18H19NO9 (393.106)

5-methoxy-4,7-bis(4-methoxyphenyl)-1,3-benzothiazol-6-ol

C22H19NO4S (393.1035)

(2r)-2-[(2r)-2-[(1r)-1-carboxyethyl]-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-6-yl]pentanedioic acid

C18H19NO9 (393.106)